Product
DBPR108
Aliases
DBPR108 tablets
2 clinical trials
2 indications
Indication
Healthy SubjectsIndication
Liver ImpairmentClinical trial
An Open-label, Single-dose, Phase I Study to Assess the Pharmacokinetics and Safety of DBPR108 Tablets in Subjects With Mild, Moderate Hepatic Impairment Compared to the Control Subjects With Normal Hepatic FunctionStatus: Completed, Estimated PCD: 2022-05-14
Clinical trial
An Open-label, Randomized, Three-period, Crossover, Single-dose Study to Evaluate the Effect of a Low-fat Meal and a Standard Meal on the Pharmacokinetics of DBPR108 in Healthy SubjectsStatus: Completed, Estimated PCD: 2022-06-07